HEALTH-RELATED QUALITY OF LIFE LOST TO ROTAVIRUS-ASSOCIATED GASTROENTERITIS IN CHILDREN AND THEIR PARENTS A CANADIAN PROSPECTIVE STUDY

被引：55

作者：

Brisson, Marc ^{[1
,2
]}

Senecal, Martin ^{[3
]}

Drolet, Melanie ^{[2
]}

Mansi, James A. ^{[3
]}

机构：

[1] Univ Quebec, Unite Rech Sante Populat, Ctr Hosp Affilie, Hop St Sacrement, Quebec City, PQ G1S 4L8, Canada

[2] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada

[3] Merck Frosst Canada Ltd, Montreal, PQ, Canada

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2010年 / 29卷 / 01期

关键词：

rotavirus; quality of life; quality-adjusted life-years (QALY); vaccines; COST-UTILITY; VACCINATION; EFFICACY; ENGLAND; SAFETY; WALES;

D O I：

10.1097/INF.0b013e3181b41506

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We estimated the impact of rotavirus-associated gastroenteritis (RGE) on health-related quality of life of children and parents as background for economic evaluation of rotavirus vaccines. A total of 186 new cases of RGE in children <36 months old were recruited from physician and pediatric clinics and followed up for 2 weeks. Our results show that RGE impacts the health-related quality of life of children and parents adversely.

引用

页码：73 / 75

页数：3

共 13 条

[1]

[Anonymous], 2013, GUID METH TECHN APPR

[2] Funding of drugs: do vaccines warrant a different approach? [J].

Beutels, Philippe ;

Scuffham, Paul A. ;

MacIntyre, C. Raina .

LANCET INFECTIOUS DISEASES, 2008, 8 (11) :727-733

[3] Varicella vaccination in England and Wales: cost-utility analysis [J].

Brisson, M ;

Edmunds, WJ .

ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (10) :862-869

[4] Modeling valuations for EuroQol health states [J].

Dolan, P .

MEDICAL CARE, 1997, 35 (11) :1095-1108

[5]

Drummond MF., 2015, Methods for the Economic Evaluation of Health Care Programmes

[6] An analytical framework for immunization programs in Canada [J].

Erickson, LJ ;

De Wals, P ;

Farand, L .

VACCINE, 2005, 23 (19) :2470-2476

[7] Quality-adjusted life-years lack quality in pediatric care: A critical review of published cost-utility studies in child health [J].

Griebsch, I ;

Coast, J ;

Brown, J .

PEDIATRICS, 2005, 115 (05) :E600-E614

[8] Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales [J].

Melegaro, A ;

Edmunds, WJ .

VACCINE, 2004, 22 (31-32) :4203-4214

[9] Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis [J].

Ruiz-Palacios, GM ;

Pérez-Schael, I ;

Velázquez, FR ;

Abate, H ;

Breuer, T ;

Clemens, SC ;

Cheuvart, B ;

Espinoza, F ;

Gillard, P ;

Innis, BL ;

Cervantes, Y ;

Linhares, AC ;

López, P ;

Macías-Parra, M ;

Ortega-Barría, E ;

Richardson, V ;

Rivera-Medina, DM ;

Rivera, L ;

Salinas, B ;

Pavía-Ruz, N ;

Salmerón, J ;

Rüttimann, R ;

Tinoco, JC ;

Rubio, P ;

Nuñez, E ;

Guerrero, ML ;

Yarzábal, JP ;

Damaso, S ;

Tornieporth, N ;

Sáez-Llorens, X ;

Vergara, RF ;

Vesikari, T ;

Bouckenooghe, A ;

Clemens, R ;

De Vos, B ;

O'Ryan, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :11-22

[10] Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study [J].

Senecal, Martin ;

Brisson, Marc ;

Lebel, Marc H. ;

Yaremko, John ;

Wong, Richard ;

Gallant, Lee Ann ;

Garfield, Hartley A. ;

Ableman, Darryl J. ;

Ward, Richard L. ;

Samjalis, John S. ;

Mansi, James A. .

CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2008, 19 (06) :397-404

← 1 2 →